Onchocerciasis
📧 Sign up to get email alerts when something new happens for Onchocerciasis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-04-07FDA Approved: IVERMECTIN — Original Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s original ANDA for ivermectin, making a generic version of the product available for human use. The app…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers [NA]
An update on a Kenya Medical Research Institute clinical trial aiming to detect and manage skin-related neglected tropical diseases in Sub-S…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Host Response to Infection and Treatment in Filarial Diseases
This clinical trial update notes an ongoing study on how hosts respond to filarial infections and their treatment, with recruitment currentl…
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Safety of a Single Dose of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas and in Individuals Living in Onchocerciasis Endemic Areas With High Levels of Lymphatic Filariasis Co-endemicity Receiving Concomitant Albendazole [Phase 3]
Phase 3 trial comparing safety of a single dose of moxidectin versus ivermectin in people living in onchocerciasis-endemic areas, including …
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for Onchocerciasis [Phase 3]
A Phase 3 study is evaluating annual or biannual dosing of moxidectin or ivermectin for onchocerciasis, with the trial currently active but …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis [Phase 2]
Phase 2 trial evaluating the safety and efficacy of novel combination regimens for onchocerciasis; the study is currently active but not rec…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Integrating Mental Health Into Neglected Tropical Disease Care in Ghana [NA]
This clinical trial update notes efforts to integrate mental health services into neglected tropical disease care in Ghana. No specific drug…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases [Phase 4]
Phase 4 clinical trial comparing moxidectin versus ivermectin for mass drug administration to control onchocerciasis and other neglected tro…
-
CLINICAL_TRIALS withdrawal · 2025-03-25Clinical Trial Update: Evaluation of the Diagnosis Performances of DEC LTS-2 Skin Patch for Onchocerciasis in Central Africa [NA]
Clinical trial update indicates the DEC LTS-2 skin patch diagnostic study for onchocerciasis (and loiasis) in Central Africa has been withdr…
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: Development of a New Rapid Diagnostic Test to Support Onchocerciasis Elimination [NA]
This clinical trial update describes the development of a new rapid diagnostic test to support elimination of onchocerciasis. Recruitment is…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients [Phase 2]
Phase 2 trial evaluating the safety and efficacy of moxidectin 2 mg in Loa loa microfilaremic patients with an ivermectin-controlled design;…
-
EMA guidance · 2025-01-31New combination of medicines to treat parasitic worm infections
EMA issued an opinion endorsing the use of a combination of ivermectin and albendazole to treat parasitic worm infections as part of global …
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: A Pharmacokinetic and Safety Study of Moxidectin to Identify an Optimal Dose for Treatment of Children 4 to 11 Years [Phase 1]
Phase 1 pharmacokinetic and safety study of moxidectin in children aged 4 to 11 years to identify an optimal dose for treating onchocerciasi…
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: A Study to Learn About How Much Emodepside Gets Absorbed in the Blood and How Food Affects Its Absorption When Given as a New Type of Tablet to Healthy Participants [Phase 1]
Phase 1 study to characterize the pharmacokinetics of emodepside and the effect of food on its absorption in healthy participants.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-4083 Capsules When Given Alone or In Combination With Albendazole Capsules Moves in The Body of Adult Participants With Onchocerca Volvulus Infection [Phase 2]
Phase 2 trial evaluating ABBV-4083 alone or with albendazole for onchocerciasis; the study was terminated but results were posted in 2024, i…
-
FDA approval · 2024-08-19FDA Approved: IVERMECTIN — Supplemental Application (Edenbridge Pharmaceuticals LLC.)
FDA approved a supplemental application for IVERMECTIN from Edenbridge Pharmaceuticals LLC (ANDA 204154). This action updates the approval s…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Clinical Trial of Rifampin and Azithromycin for the Treatment of River Blindness [Phase 2]
A Phase 2 CDC-sponsored trial evaluating rifampin in combination with azithromycin for Onchocerciasis has completed.
-
CLINICAL_TRIALS trial_result · 2024-03-05Clinical Trial Update: Emodepside Phase II Trial for Treatment of Onchocerciasis [Phase 2]
A Phase II clinical trial of emodepside for treating onchocerciasis is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: Safety and Efficacy of IDA for Onchocerciasis [Phase 2]
A Phase 2 clinical trial evaluating the safety and efficacy of IDA (Ivermectin, Diethylcarbamazine, and Albendazole) for Onchocerciasis has …
-
CLINICAL_TRIALS trial_result · 2022-12-15Clinical Trial Update: Study Evaluating Orally Administered Moxidectin In Subjects With Onchocerca Volvulus Infection [Phase 2]
Phase 2 trial update evaluating orally administered moxidectin for Onchocerciasis has completed.
-
FDA approval · 2022-08-02FDA Approved: IVERMECTIN — Original Application (Viona Pharmaceuticals Inc)
FDA approves an original ANDA for ivermectin tablets from Viona Pharmaceuticals Inc, enabling a generic version of the antiparasitic for cer…
-
FDA approval · 2020-07-09FDA Approved: IVERMECTIN — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Actavis Pharma’s ivermectin, confirming approval of its generic antiparasitic product.
-
CLINICAL_TRIALS trial_result · 2019-04-26Clinical Trial Update: Efficacy of Ivermectin and Albendazole Against Onchocerciasis in the Volta Region, Ghana [Phase 3]
Phase 3 clinical trial evaluating the efficacy of ivermectin and albendazole against onchocerciasis in the Volta Region, Ghana has completed…
-
CLINICAL_TRIALS trial_result · 2018-05-04Clinical Trial Update: Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Ivory Coast (DOLF-Ivory Coast)
This clinical trial update describes efforts to optimize mass drug administration regimens for lymphatic filariasis and onchocerciasis in Iv…
-
CLINICAL_TRIALS trial_result · 2018-01-31Clinical Trial Update: Study Comparing Moxidectin And Ivermectin In Subjects With Onchocerca Volvulus Infection [Phase 3]
Phase 3 trial comparing moxidectin and ivermectin for onchocerciasis has completed.